Benjamin Graham · Defensive deep-value investing
Is Alnylam Pharmaceuticals, Inc. (ALNY) a Benjamin Graham Stock?
Meets 2/7 Graham criteria, classic deep-value candidate.
76/100
Does not fit
2/7 criteria passed
Benjamin Graham's Criteria, Applied to ALNY
P/E ≤ 15
key68.1x
P/B ≤ 1.5
key36.5x
Current ratio ≥ 2
3.1x
Debt / Equity ≤ 1
1.2x
How ALNY Scores on Other Strategies
Live Financial Snapshot
Market cap
$23.28B
P/E (TTM)
68.1x
ROIC (TTM)
19.66%
Gross margin
80.89%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is ALNY's Benjamin Graham fit score?
ALNY scores 76/100 on our Benjamin Graham fit engine. Meets 2/7 Graham criteria, classic deep-value candidate.
Does Benjamin Graham actually own ALNY?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends ALNY.
How often is this score updated?
ALNY's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends ALNY.
